XML 39 R29.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2024
Stock-Based Compensation  
Schedule of stock-based compensation expense

Stock-based compensation expense as reflected in the Company’s condensed consolidated statements of operations and comprehensive loss was as follows (in thousands):

Three months ended
September 30,

Nine months ended
September 30, 

    

2024

    

2023

2024

    

2023

Research and development

$

327

$

184

$

867

$

485

General and administrative

 

827

 

659

 

2,236

 

2,566

Stock-based compensation expense included in operating expenses

$

1,154

$

843

$

3,103

$

3,051

Summary of stock option activity

The following is a summary of the Company’s stock option activity for the nine months ended September 30, 2024:

    

    

Weighted- 

    

Weighted- average 

    

Aggregate 

average 

remaining contractual 

intrinsic value

Options

exercise price

term (in years)

(in thousands)

Outstanding at December 31, 2023

 

4,178,194

$

2.98

 

8.22

$

11

Granted

 

2,702,050

2.94

 

 

Exercised

(379,425)

1.31

Cancelled

(251,931)

4.43

Outstanding at September 30, 2024

 

6,248,888

$

3.01

 

4.44

$

2

Vested at September 30, 2024

2,607,444

$

3.54

$

Vested and expected to vest at September 30, 2024

 

6,248,888

$

3.01

 

4.44

$

2

The following is a summary of the Company’s stock option activity for the nine months ended September 30, 2023:

    

    

Weighted- 

    

Weighted- average 

    

Aggregate 

average 

remaining contractual 

intrinsic value

Options

exercise price

term (in years)

(in thousands)

Outstanding at December 31, 2022

 

4,408,274

$

3.44

 

8.52

$

350

Granted

 

2,367,139

1.10

 

 

Exercised

(1,264,899)

1.18

Cancelled

(1,074,995)

2.67

Outstanding at September 30, 2023

 

4,435,519

$

3.02

 

8.48

$

25

Vested at September 30, 2023

2,807,686

$

3.27

5.55

$

22

Vested and expected to vest at September 30, 2023

 

4,435,519

$

3.02

 

8.48

$

25

Schedule of assumptions used in estimation of fair value

    

Three months ended September 30, 

 

Nine months ended September 30, 

 

2024

    

2023

 

2024

    

2023

 

Risk-free interest rate

 

3.46 - 4.15

%  

4.02 - 4.20

%

3.46 - 4.65

%  

3.67 - 4.24

%

Volatility

 

75 - 76

%  

72 - 73

%

72 - 76

%  

72 - 74

%

Dividend yield

 

0.00

%  

0.00

%

0.00

%  

0.00

%

Expected term (years)

 

6

 

6

6 - 7

 

2 - 7

Summary of restricted stock units activity

The following table summarizes activity related to RSUs:

    

    

Weighted- average

grant date

Number of shares

fair value

Unvested at December 31, 2023

 

155,797

$

8.25

Granted

 

437,025

$

2.77

Vested

(66,589)

$

9.48

Cancelled

(27,400)

$

2.28

Unvested at September 30, 2024

 

498,833

$

3.61